There are few areas of the healthcare space that are causing as much excitement, or have as much potential, as CRISPR.
The gene editing technology is fascinating stuff and, in this video, our diagnostic experts Eleanor Doolin and Adam Hargreaves looked into the science behind it.
We also spoke to Ishani Dasgupta, Gene Therapy Scientist and Bill Standwill, Head of Commercial from CRISPR diagnostic pioneers Sherlock Biosciences for their expert insight.
If you have any questions for Eleanor and Adam, you can reach out to them directly at eleanor.doolin@lifesci-cm.com and adam.hargreaves@lifesci-cm.com.
Alongside the growing trend of value-based searches, I wanted to delve into why candidates prioritise companies that focus on fundamental principles and ethics which resonate with them, as opposed to other more material benefits. Find out why, here.
In this episode, Jack speaks with two Co-Founders at Centivax about life as successful entrepreneurs, the journey to acquisition, challenges and learnings - and using them to become an industry-defining author. Listen now.
In this episode, Jack speaks with Twlya Tiongson Neal, Managing Director at Accenture, about commercial strategy and what this really looks like in the current life science landscape. Click to listen.
Comments.